Approval · Notice of Compliance 29401 · 2022
SALOFALK: Notice of Compliance 29401
Issued November 7, 2022
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 29401
- Date
- November 7, 2022
- Company
- AbbVie CorporationSaint-Laurent, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Administrative: Change in Product Ownership
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| SALOFALK | 02112787 | Marketed |
Medicinal ingredients
- MESALAZINE 500 MG per TAB